Forge Biologics
Industry
- Contract Manufacturing Organization
- Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
- Pharmaceuticals
Latest on Forge Biologics
The Foundation for the National Institutes of Health’s Bespoke Gene Therapy Consortium is offering a regulatory guidebook to help investigators navigate the investigational new drug application submis
Diversified major Japanese foods firm Ajinomoto Co., Inc. is to acquire the US gene therapy-focused contract development and manufacturing organization (CDMO) Forge Biologics for approximately $554m
The number of investigational drugs that the European Medicines Agency accepted onto PRIME, its scheme for promising medicines for unmet medical needs, fell to a record low in 2022. Thirteen products
A bevy of big venture capital financings have been announced since Labor Day, the official end of summer in the US, led by a $300m series C round for Acelyrin, Inc. The boom in VC mega-deals is rema